Clinical Trial Update: Antithrombin III in Infectious Disease Caused by COVID-19 [Phase 2]

View source ↗

Summary

Phase 2 trial investigating Antithrombin III for infectious disease caused by COVID-19 was terminated; results posted in 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Antithrombin Iii Deficiency

Drugs mentioned

• Antithrombin III (antithrombin III)

Snippet

Sponsor: Enrique Ginzburg | Conditions: Antithrombin III Deficiency, Covid19 | Phase 2 | Status: TERMINATED | Results posted: 2022-09-07